Abstract
Purpose of review
Maternal mortality in the United States is highest among all developed nations and continues to rise. The leading cause of morbidity and mortality during pregnancy and the postpartum period is cardiovascular disease. While there are large European and Canadian studies exploring the care and outcomes of moms with heart disease in pregnancy, there are no large prospective studies to guide the care of this growing group of patients in the US. We review the current approach to the management of patients with heart disease in pregnancy and the gaps in knowledge thereof.
Recent findings
Currently, antenatal management and delivery planning are highly variable for patients with heart disease in pregnancy and maternal risk models’ application to the US patient population is limited by their derivation from an international cohort of patients and their focus on patients with congenital heart disease. As the need for interdisciplinary care between cardiologists and obstetricians becomes evident, and as broad research efforts within this space are very much needed, we propose a research collaborative called the Heart Outcomes in Pregnancy: Expectations (HOPE) for Mom and Baby Registry. The HOPE Registry aims to address key clinical questions surrounding the preconception period, antenatal care, delivery planning and outcomes, and long-term postpartum care and outcomes of these unique patients.
Summary
We have made progress in recent years by recognizing the clinical need to address and standardize the management of patients with heart disease in pregnancy. We now must initiate and propel US-based cardio-obstetrics research to address key gaps in knowledge and variability in the care of patients with heart disease in pregnancy.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance
Centers for Disease Control and Prevention. Pregnancy mortality surveillance system. http://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html. Updated August 7 AM, 2019.
MacDorman MFDE, Cabral H, Morton C. Recent increases in the US maternal mortality rate: disentangling trends from measurement issues. Obstet Gynecol. 2016;128(3):447–5.
National Center for Health Statistics. Report of the panel to evaluate the US standard certificates. Hyattsville MNCfHSAfhw.
Minino AM MS, XU J, Kochanek KD. National vital statistics report. Vol 59. National Center for Health Statistics; 2011. Deaths: Final data for 2008. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_10.pdf. [accessed May 2, 2019].
Review to Action. Report from nine maternal mortality review committees. https://reviewtoaction.org/Report_from_Nine_MMRCs. Accessed March 12.
Zaharatos JSPA, Cornell A, Pasalic E, Goodman D. Building U.S. capacity to review and prevent maternal deaths. J Women's Health (Larchmt). 2018;27(1):1–5.
Moaddab ADG, Brown H, Bateni ZH, et al. Health care disparity and pregnancy-related mortality in the United States, 2005-2014. Obstet Gynecol. 2018;131(4):707–12.
Creanga ASC, Seed K, Callaghan W. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol. 2017;130(2):366–73.
Stevenson AJF-VI, Allgeyer RL, Schenkkan P, et al. Effect of removal of planned parenthood from the Texas Women’s Health Program. NEJM. 2016;374(9):853–60.
Liptak A. Supreme court appears sharply divided as it hears Texas abortion case. New York Times; Mar 2 Aahwnc
Main EKMC, Morton CH, Holtby S, Lawton EL. Pregnancy-related mortality in California. Obstet Gynecol. 2015;125(4):938–47.
Leise KLMM, Abboud S, Decocker K, Koch A, Geller SE. J Racial Ethn Health Disp. 2019.
Optimizing postpartum care. ACOG Committee opinion no. 736. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018;131:e140–50.
ACOG Practice Bulletin No. 212. Pregnancy and heart disease. Obstet Gynecol. 2019;133(5):e320–56 These guidelines reflect new guidance on how to treat the leading cause of U.S. maternal deaths: heart disease in pregnancy. This stresses the importance of sooner 1 month postpartum follow up for patients with heart disease in pregnancy.
Briller JKA, Geller SE. Maternal cardiovascular mortality in Illinois, 2002-2011. Obstet Gynecol. 2017;129:819–26.
Siu SCSM, Coman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, et al. Cardiac disease in pregnancy (CARPREG) investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515–21.
Silversides CGJ, Mason J, Sermer M, Kiess M, Rychel V, Wald R, et al. Pregnancy outcomes in women with heart disease. The CARPREG II Study. J Am Col Cardiol. 2018;71:2419–30.
Wolfe DSHA, Taub C, Zaidi AN, Bortnick AE. Addressing maternal mortality: the pregnancy cardiac patient. AJOG. 2019;220(2):167.e1–76.e8 A proposed triad approach to improving maternal mortality attributable to cardiac disease included universal screening for cardiovascular disease in pregnancy and postpartum women, patient education, and institution of a multidisciplinary cardiac team.
Nora ANJ, Optiz J, Reynolds J. Update on counseling the fam-ily with a first-degree relative with a congenital heart defect. Am J Med Genet. 1988;29:137–42.
Gelson ECR, Gatzoulis MA, Swan L, Lupton M, Steer P, Johnson M. Effect of maternal heart disease on fetal growth. Obstet Gynecol. 2011;117(4):886–91. https://doi.org/10.1097/AOG.0b013e31820cab69 Erratum in: Obstet Gynecol. 2011 Aug;118(2 Pt 1):364. PubMed PMID: 21422861.
Vasapollo BVH, Novelli GP, Altomare F, Galante A, Arduini D. fetal Amcfptcmo, PMID: grUOGJ-P, 15229912.
Ford AAWB, Waksmonski CA, Simpson LL. Maternal congenital cardiac, Gynecol. doopiastccO, 18827125. O-dAbecPP.
Circ WCPaDiWWCHD, Review. J-dcC--EJ, 26040336. PP.
Furenäs E EP, Wennerholm UB, Dellborg M. Effect of maternal age and, heart cdsooopiwwc, dIJCS-, 28539207.
Volløyhaug IMS, Salvesen Ø, Salvesen KÅ. Pelvic organ prolapse and incontinence 15-23 years after first delivery: a cross-sectional study. BJOG. 2015;122(7):964–71.
Enriquez ADEK, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7:961–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Pregnancy and Cardiovascular Disease
Rights and permissions
About this article
Cite this article
Grodzinsky, A., Florio, K., Spertus, J.A. et al. Maternal Mortality in the United States and the HOPE Registry. Curr Treat Options Cardio Med 21, 42 (2019). https://doi.org/10.1007/s11936-019-0745-0
Published:
DOI: https://doi.org/10.1007/s11936-019-0745-0